Matthew M. Hutmacher

693 total citations
31 papers, 554 citations indexed

About

Matthew M. Hutmacher is a scholar working on Statistics and Probability, Economics and Econometrics and Rheumatology. According to data from OpenAlex, Matthew M. Hutmacher has authored 31 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Statistics and Probability, 7 papers in Economics and Econometrics and 5 papers in Rheumatology. Recurrent topics in Matthew M. Hutmacher's work include Statistical Methods in Clinical Trials (8 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Statistical Methods and Bayesian Inference (6 papers). Matthew M. Hutmacher is often cited by papers focused on Statistical Methods in Clinical Trials (8 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Statistical Methods and Bayesian Inference (6 papers). Matthew M. Hutmacher collaborates with scholars based in United States, United Kingdom and France. Matthew M. Hutmacher's co-authors include Kenneth G. Kowalski, Sriram Krishnaswami, Raymond Miller, Jonathan French, Sujatha Menon, Joseph C. Fleishaker, Sunny Chapel, Richard L. Lalonde, Lynn McFadyen and Kaori Ito and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Statistics in Medicine.

In The Last Decade

Matthew M. Hutmacher

31 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew M. Hutmacher United States 14 168 92 76 75 68 31 554
Matt Hutmacher United States 11 155 0.9× 127 1.4× 72 0.9× 69 0.9× 77 1.1× 15 618
Carol Cronenberger United States 13 46 0.3× 67 0.7× 44 0.6× 78 1.0× 173 2.5× 28 540
Stacey Tannenbaum United States 13 66 0.4× 233 2.5× 29 0.4× 103 1.4× 241 3.5× 24 840
Hugo Maas Germany 12 77 0.5× 161 1.8× 244 3.2× 16 0.2× 45 0.7× 22 1.7k
Anja Schiel Norway 13 125 0.7× 150 1.6× 35 0.5× 24 0.3× 89 1.3× 24 582
William M. Sallas United States 10 35 0.2× 194 2.1× 162 2.1× 30 0.4× 49 0.7× 19 758
Jacqueline Corrigan‐Curay United States 9 106 0.6× 135 1.5× 119 1.6× 14 0.2× 45 0.7× 13 616
Lutz Harnisch United States 10 107 0.6× 140 1.5× 53 0.7× 6 0.1× 51 0.8× 31 574
H. Amy Xia United States 15 276 1.6× 44 0.5× 19 0.3× 151 2.0× 284 4.2× 27 776
Satrajit Roychoudhury United States 15 772 4.6× 96 1.0× 55 0.7× 22 0.3× 46 0.7× 38 1.1k

Countries citing papers authored by Matthew M. Hutmacher

Since Specialization
Citations

This map shows the geographic impact of Matthew M. Hutmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Hutmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Hutmacher more than expected).

Fields of papers citing papers by Matthew M. Hutmacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Hutmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Hutmacher. The network helps show where Matthew M. Hutmacher may publish in the future.

Co-authorship network of co-authors of Matthew M. Hutmacher

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Hutmacher. A scholar is included among the top collaborators of Matthew M. Hutmacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Hutmacher. Matthew M. Hutmacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ying, Michael A. Tortorici, Dipti Pawaskar, et al.. (2018). Exposure‐Response Model of Subcutaneous C1‐Inhibitor Concentrate to Estimate the Risk of Attacks in Patients With Hereditary Angioedema. CPT Pharmacometrics & Systems Pharmacology. 7(3). 158–165. 12 indexed citations
2.
3.
Hutmacher, Matthew M.. (2016). Evaluation of estimation, prediction and inference for autocorrelated latent variable modeling of binary data—a simulation study. Journal of Pharmacokinetics and Pharmacodynamics. 43(3). 275–289. 2 indexed citations
4.
Gupta, Neeraj, et al.. (2015). Integrated nonclinical and clinical risk assessment of the investigational proteasome inhibitor ixazomib on the QTc interval in cancer patients. Cancer Chemotherapy and Pharmacology. 76(3). 507–516. 24 indexed citations
5.
Nori, Mukund, et al.. (2015). Population pharmacokinetics of pegaptanib sodium (Macugen®) in patients with diabetic macular edema. Clinical ophthalmology. 9. 323–323. 12 indexed citations
6.
Hutmacher, Matthew M., et al.. (2015). Application of a hazard-based visual predictive check to evaluate parametric hazard models. Journal of Pharmacokinetics and Pharmacodynamics. 43(1). 57–71. 13 indexed citations
7.
Nielsen, Jace, et al.. (2014). Population dose‐response analysis of daily seizure count following vigabatrin therapy in adult and pediatric patients with refractory complex partial seizures. The Journal of Clinical Pharmacology. 55(1). 81–92. 5 indexed citations
8.
Isaacs, John D., Andrea Zuckerman, Sriram Krishnaswami, et al.. (2014). Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials. Arthritis Research & Therapy. 16(4). R158–R158. 37 indexed citations
9.
Hutmacher, Matthew M. & Kenneth G. Kowalski. (2014). Covariate selection in pharmacometric analyses: a review of methods. British Journal of Clinical Pharmacology. 79(1). 132–147. 57 indexed citations
10.
Stroh, Mark, et al.. (2013). Simultaneous Pharmacokinetic Model for Rolofylline and both M1-trans and M1-cis Metabolites. The AAPS Journal. 15(2). 498–504. 3 indexed citations
11.
Mendizábal, Nieves Vélez de, Matthew M. Hutmacher, Iñaki F. Trocóniz, et al.. (2013). Predicting Relapsing-Remitting Dynamics in Multiple Sclerosis Using Discrete Distribution Models: A Population Approach. PLoS ONE. 8(9). e73361–e73361. 11 indexed citations
12.
Nielsen, Jace, Matthew M. Hutmacher, Adriaan Cleton, Steven W. Martin, & Jakob Ribbing. (2012). Longitudinal FEV1 dose–response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease. Journal of Pharmacokinetics and Pharmacodynamics. 39(6). 619–634. 10 indexed citations
13.
Bursi, Roberta, Gül Erdemli, Robert A. Campbell, et al.. (2011). Translational PK–PD modelling of molecular target modulation for the AMPA receptor positive allosteric modulator Org 26576. Psychopharmacology. 218(4). 713–724. 13 indexed citations
14.
Miller, Raymond, et al.. (2009). Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorder. Journal of Pharmacokinetics and Pharmacodynamics. 36(6). 565–584. 21 indexed citations
15.
Hutmacher, Matthew M., et al.. (2008). Performance Characteristics for Some Typical QT Study Designs Under the ICH E‐14 Guidance. The Journal of Clinical Pharmacology. 48(2). 215–224. 33 indexed citations
16.
Hutmacher, Matthew M., et al.. (2007). Modeling the Exposure‐Response Relationship of Etanercept in the Treatment of Patients With Chronic Moderate to Severe Plaque Psoriasis. The Journal of Clinical Pharmacology. 47(2). 238–248. 9 indexed citations
17.
Hutmacher, Matthew M., Sriram Krishnaswami, & Kenneth G. Kowalski. (2007). Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients. Journal of Pharmacokinetics and Pharmacodynamics. 35(2). 139–157. 50 indexed citations
18.
Hutmacher, Matthew M., et al.. (2005). Collapsing Mechanistic Models: An Application to Dose Selection for Proof of Concept of a Selective Irreversible Antagonist. Journal of Pharmacokinetics and Pharmacodynamics. 32(3-4). 501–520. 10 indexed citations
19.
Kowalski, Kenneth G., et al.. (2003). A Two-Part Mixture Model for Longitudinal Adverse Event Severity Data. Journal of Pharmacokinetics and Pharmacodynamics. 30(5). 315–336. 30 indexed citations
20.
Kowalski, Kenneth G. & Matthew M. Hutmacher. (2001). Efficient Screening of Covariates in Population Models Using Wald's Approximation to the Likelihood Ratio Test. Journal of Pharmacokinetics and Pharmacodynamics. 28(3). 253–275. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matt Hutmacher Breakdown of academic impact, for papers by Carol Cronenberger Breakdown of academic impact, for papers by Stacey Tannenbaum Breakdown of academic impact, for papers by Hugo Maas Breakdown of academic impact, for papers by Anja Schiel Breakdown of academic impact, for papers by William M. Sallas Breakdown of academic impact, for papers by Jacqueline Corrigan‐Curay Breakdown of academic impact, for papers by Lutz Harnisch Breakdown of academic impact, for papers by H. Amy Xia Breakdown of academic impact, for papers by Satrajit Roychoudhury
Rankless by CCL
2026